PlainRecalls
FDA Drug Moderate Class II Terminated

Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL), (PE= phenytoin sodium equivalents) 10 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-403-10

Reported: July 16, 2014 Initiated: May 2, 2014 #D-1429-2014

Product Description

Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL), (PE= phenytoin sodium equivalents) 10 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-403-10

Reason for Recall

Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
728,880 vials
Distribution
Nationwide and Puerto Rico
Location
Melrose Park, IL

Frequently Asked Questions

What product was recalled?
Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL), (PE= phenytoin sodium equivalents) 10 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-403-10. Recalled by Fresenius Kabi USA, LLC. Units affected: 728,880 vials.
Why was this product recalled?
Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 16, 2014. Severity: Moderate. Recall number: D-1429-2014.